PSYCH 115 Lecture Notes - Lecture 16: Cognitive Therapy, Fluoxetine, Lorazepam
Document Summary
Anxiety, worry, or fear of another attack. Concern about being unable to escape or get help in the event of panic symptoms or other unpleasant physical symptoms (e. g. , incontinence, vomiting, falling) Use and abuse of drugs and alcohol. Acute onset, most common in young adulthood (e. g. ages 20-24) Earlier cognitive development > fewer cognitive symptoms (e. g. less fear of dying) Changes in prevalence decreases with age. Diagnostic criteria for agoraphobia change in behavior. At least one attach has been followed by significant worry or maladaptive. Marked fear/anxiety for two or more: public transportation, open spaces, Anxiety is excessive enclosed spaces, standing in line, being outside the home alone. Not better explained by another mental disorder. ~75% of those with agoraphobia are female. Somatic symptoms more emphasized than emotional symptoms in developing countries. 60% with panic disorder experience nocturnal attacks. Sensations of letting go are anxiety provoking to people with panic attacks. High relapse rates after discontinuation of medication.
